In September 2024, the Australian Government published the final report of the Health Technology Assessment (HTA) Policy and Methods Review. On the surface, it is a national reform document. In …
#intellectualproperty
-
-
Why access preparedness has become a strategic asset in 2026 Europe still enters many life-science strategy discussions as a question of timing rather than design. Launch later, once the US …
-
What Medicare’s DMHT Codes Signal for Digital Therapeutics Reimbursement and Why Healthcare Is Paying Attention Digital therapeutics reimbursement refers to how public and private healthcare systems pay for evidence-based software …
-
France 2030 medical device funding is a major public investment opportunity for teams developing implantable medical devices and next-generation surgical robotics. Managed via Bpifrance under the France 2030 investment plan, …
-
How Reimbursement Actually Works in Poland This paper explains how reimbursement in Poland actually works for MedTech, IVD, digital health, and AI technologies — including the role of NFZ, DRGs …
-
The HAS / CNEDiMTS route explained science, law, and real-world decisions France operates one of the most structured and evidence-based reimbursement systems for medical devices in Europe. Access is not …
-
Why KVÅ Procedure Reimbursement Matters in Sweden KVÅ procedure reimbursement is one of the most powerful—but often misunderstood—mechanisms in the Swedish healthcare system. What appears to be a simple six-character …
-
How Scientific Abstracts and Reimbursement Really Connect in MedTech and Digital Health This article explains how scientific abstracts and reimbursement are linked in the MedTech, IVD, and digital health sectors. …